Convergence Insufficiency Clinical Trial
— VRVT - VERVEOfficial title:
Effectiveness of Vision Therapy in a Virtual Reality Headset
The purpose of this research study is to see how well the treatment of a participant's eye coordination and/or focusing problems improves eye muscle responses and symptoms of eyestrain. We will use an entertainment device called a virtual reality headset to play a custom-designed video game to find out how well the treatment of binocular vision improves a participant's coordination and/or focusing problem. The virtual reality headset uses eye-trackers to monitor progress in a totally objective manner. Objective testing allows the doctor to determine the results without relying on a participant's ability to answer questions or respond verbally in any way. We will compare the results of a participant before and after playing the video game.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | September 2024 |
Est. primary completion date | August 28, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 9 Years to 35 Years |
Eligibility | Inclusion Criteria: - Age 9 years and older - CISS score = 16 - Best-corrected distance visual acuity of 20/25 or better in each eye - Random dot stereopsis appreciation of 500 seconds of arc or better - Parent or subject understands the protocol and is willing to enroll in the study Exclusion Criteria: - Constant strabismus at distance or near - Vertical heterophoria = 2 ? at distance or near - = 2 line interocular difference in best-corrected visual acuity - Near point of accommodation > 20 cm in either eye as measured by push-up method - Manifest or latent nystagmus - Non-strabismic binocular vision and accommodative disorders associated with known disease of the brain - Diseases known to affect accommodation, vergence, or ocular motility such as multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, Parkinson disease - Any ocular or systemic medication known to affect accommodation or vergence such as anti-anxiety agents (e.g., Librium or Valium), anti-arrhythmic agents (e.g., Cifenline, Cibenzoline), anti-cholinergics, bladder spasmolytic drugs (e.g., Propiverine), hydroxychloroquine, chloroquine, phenothiazines (e.g., Compazine, Mellaril, Thorazine), tricyclic antidepressants (e.g., Elavil, Nortriptyline, Tofranil) - Inability to comprehend and/or perform any study-related test or procedure |
Country | Name | City | State |
---|---|---|---|
United States | OculoMotor Technologies | Newark | New Jersey |
United States | The Eye Institute at Salus University | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
OculoMotor Technologies | New Jersey Institute of Technology, Salus University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Positive Fusional Vergence | Normal range is >15 Prism Diopters | up to 4 weeks post-therapy | |
Primary | Near Point of Convergence | Normal range is < 6 cm | up to 4 weeks post-therapy | |
Secondary | Convergence Insufficiency Symptom Survey (CISS) | Normal range is < 21 for adults and < 16 for pediatrics | up to 4 weeks post-therapy | |
Secondary | Vision Quality of Life with Time Survey (VisQuaL-T) | Normal range is > 2.5 | up to 4 weeks post-therapy | |
Secondary | Core Elements of Gaming Experience Questionnaire | User experience rating | up to 4 weeks post-therapy |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03248336 -
Objective Assessment of Disparity Vergence After Treatment of Symptomatic CI in Children
|
N/A | |
Recruiting |
NCT05262361 -
Persistent Post-Concussion Symptoms With Convergence Insufficiency
|
N/A | |
Terminated |
NCT03123822 -
Spectacles Lens in Concussed Kids
|
N/A | |
Completed |
NCT00472407 -
Screening for Convergence Insufficiency in School-age Children
|
||
Completed |
NCT00347945 -
Randomized Trial of Treatments for Convergence Insufficiency
|
Phase 3 | |
Completed |
NCT05070767 -
Neurolens Headache Study
|
N/A | |
Completed |
NCT03319966 -
Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
|
||
Terminated |
NCT05087563 -
Neurolens Convergence Insufficiency Study
|
N/A | |
Completed |
NCT02607384 -
The Baltimore Reading and Eye Disease Study
|
N/A | |
Active, not recruiting |
NCT02207517 -
Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency
|
Phase 3 | |
Completed |
NCT00347581 -
A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children
|
Phase 3 | |
Recruiting |
NCT05603962 -
The Effectiveness of Visual Training in Convergence Insufficiency Patients
|
N/A | |
Completed |
NCT01515943 -
Convergence Insufficiency Treatment Study (CITS)
|
N/A | |
Recruiting |
NCT05877560 -
Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency
|
N/A | |
Recruiting |
NCT05948046 -
The Health-Related Quality of Life of the Patients With Symptomatic Convergence Insufficiency
|
||
Active, not recruiting |
NCT00338611 -
Convergence Insufficiency Treatment Trial (CITT)
|
Phase 3 | |
Recruiting |
NCT05012384 -
Effect of Vergence Exercises for Patients With Convergence Insufficiency After Concussion.
|
N/A | |
Recruiting |
NCT05761106 -
Effect of Exercises on Convergence Insufficiency in Individuals With Temporomandibular Disorders
|
N/A | |
Completed |
NCT02510040 -
A Prospective Observational Study of Adult Strabismus
|
||
Recruiting |
NCT05311917 -
Home Vision Therapy and Prism Prescription in Presbyopic Persons With Convergence Insufficiency
|
N/A |